I honestly think, at these levels, and with 2 very late stage drugs, and 1 other compound in the clinic, they are past the PIPE level scams.
they're going to have to raise money one way or the other. The fact that Berger is saying they are not out there looking for money, to me, either means they (1) are certain to have a large partner lined up for Ponatanib (Asia)(would they actually go it alone there?), or (2) he's not being truthful and is going to lose a tremendous amount of respect from Wall Street, which, simply by the compounds, he has earned back somewhat over the past 2 years (after being in the dumps).